maca root

Botanicalexperimental

Lepidium meyenii, known as maca or Peruvian ginseng, is an edible herbaceous biennial plant of the family Brassicaceae that is native to South America in the high Andes mountains of Peru and Bolivia. It was rediscovered for commercial purposes at the Meseta de Bombón plateau close to Lake Junin in the late 1980s. It is grown for its fleshy hypocotyl that is fused with a taproot, which is typically dried but may also be freshly cooked as a root vegetable. As a cash crop, it is primarily exported as a powder that may be raw or processed further as a gelatinized starch or as an extract. If dried, it may be processed into a flour for baking or as a dietary supplement. — Wikipedia

Clinical trial activity

3 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
3
Phase 3
3
Phase 4
0

Earliest trial started Apr 1, 2005 (NCT00181961)

Timeline

2000s

  1. Jan 1, 2005

    Earliest Phase 3 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • maca root

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00568126Phase 3Nov 1, 2007Harvard University, National Institutes of Health (NIH)
NCT00575328Phase 3Nov 1, 2007Brain & Behavior Research Foundation, Harvard University
NCT00181961Phase 3Apr 1, 2005Harvard University
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Harvard UniversityAcademic/Hospital3312005
Brain & Behavior Research FoundationAcademic/Hospital1012007
National Institutes of Health (NIH)Government1012007
3 organizations
Page 1 / 1